Stevanato Group S.p.A (STVN) Total Non-Current Liabilities (2020 - 2026)

Stevanato Group S.p.A's (STVN) quarterly Total Non-Current Liabilities came in at -$89.9 million in Q1 2026, down 3.36% year-on-year from -$93.0 million in Q1 2025, and down 2.44% on a QoQ basis from -$87.8 million in Q4 2025.

Stevanato Group S.p.A (STVN) Total Non-Current Liabilities (2020 - 2026) Analysis & Trends

Stevanato Group S.p.A (STVN) has 7 years of Total Non-Current Liabilities data on file, last reported at -$89.9 million in Q1 2026.

  • On a quarterly basis, Total Non-Current Liabilities fell 3.36% year-over-year to -$89.9 million in Q1 2026; TTM through Mar 2026 was -$89.9 million, a 3.36% decrease from a year earlier, with the FY2025 full-year figure at -$87.8 million, up 3.71% from the prior year.
  • Total Non-Current Liabilities for Q1 2026 stood at -$89.9 million, down from -$87.8 million in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for STVN reached as high as -$39.3 million in Q2 2022 and fell as low as -$91.2 million in Q3 2025.
  • Historically, Total Non-Current Liabilities has averaged -$73.3 million across 5 years, with a median of -$78.8 million in 2024.
  • Across the five-year window, Total Non-Current Liabilities slumped 116.16% in 2022 and grew 3.71% in 2025, its largest moves.
  • Year by year, Total Non-Current Liabilities stood at -$54.0 million in 2022, then tumbled by 38.55% to -$74.8 million in 2023, then declined by 21.9% to -$91.2 million in 2024, then increased by 3.71% to -$87.8 million in 2025, then retreated by 2.44% to -$89.9 million in 2026.
  • Per Business Quant data, the three most recent Total Non-Current Liabilities figures were -$89.9 million in Q1 2026, -$87.8 million in Q4 2025, and -$91.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Alcon 32,734,969.19 Bn 32,734,967.53 Bn 1.53 Bn 6.48 Bn
2 Intuitive Surgical 117.50 Bn 112.41 Bn 1.96 Bn 1.92 Bn
3 Becton Dickinson 42.93 Bn 42.11 Bn 2.15 Bn 48.37 Bn
4 Medline 30.82 Bn 36.66 Bn 1.84 Bn 17.13 Bn
5 Resmed 27.90 Bn 26.23 Bn 890.98 Mn 941.16 Mn
6 West Pharmaceutical Services 26.76 Bn 26.23 Bn 329.20 Mn 996.30 Mn
7 Cooper Companies 15.30 Bn 15.16 Bn 735.40 Mn 4.24 Bn
8 Solventum 13.46 Bn 12.90 Bn 1.10 Bn 8.65 Bn
9 Align Technology 12.02 Bn 10.96 Bn 736.59 Mn 2.06 Bn
10 Stevanato Group S.p.A 5.29 Bn 5.15 Bn 88.01 Mn -89.91 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -89.91 Mn
Dec 31, 2025 -87.77 Mn
Sep 30, 2025 -91.19 Mn
Jun 30, 2025 -88.41 Mn
Mar 31, 2025 -86.99 Mn
Dec 31, 2024 -91.15 Mn
Sep 30, 2024 -81.38 Mn
Jun 30, 2024 -78.83 Mn
Mar 31, 2024 -78.65 Mn
Dec 31, 2023 -74.78 Mn
Sep 30, 2023 -80.45 Mn
Jun 30, 2023 -74.05 Mn
Mar 31, 2023 -57.32 Mn
Dec 31, 2022 -53.97 Mn
Sep 30, 2022 -51.02 Mn
Jun 30, 2022 -39.27 Mn
Mar 31, 2022 -41.41 Mn
Dec 31, 2021 -41.53 Mn
Sep 30, 2021 315.78 Mn
Jun 30, 2021 355.10 Mn